Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in mice

Mayo, 1972, Biologic characterization of the subcutaneously implanted Lewis lung tumor, Cancer Chemother. Rep., 3, 325 Willis, 1973 Merker, 1978, Effectiveness of clinically active antineoplastic drugs in a surgical-adjuvant chemotherapy treatment regimen using the Lewis Lung (LL) carcinoma, Int. J. Cancer, 21, 482, 10.1002/ijc.2910210414 Schabel, 1976, Nitrosoureas: a review of experimental antitumor activity, Cancer Treat. Rep., 60, 665 Griswold, 1975, The potential for murine tumor models in surgical adjuvant chemotherapy, Cancer Chemother. Rep., 5, 187 Martin, 1970, Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy, Cancer Res., 30, 709 Van De Velde, 1977, A new metastasizing mammary carcinoma model in mice: model characteristics and applications, Europ. J. Cancer, 13, 555, 10.1016/0014-2964(77)90117-7 Dasdia, 1974, Biological changes and antitumoral drug sensitivity of two cell lines derived from Moloney virus-induced sarcoma, Biochem. exp. Biol., 11, 131 Di Marco, 1976, Biological properties of cell lines derived from Moloney virus-induced sarcoma, Tumori, 62, 415, 10.1177/030089167606200408 Giuliani, 1974, Virologic and immunologic properties and response to daunomycin and adriamycin of a non-regressing mouse tumor derived from MSV-induced sarcoma, Biomedicine, 21, 435 Giuliani, 1978, Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma, Europ. J. Cancer, 14, 555, 10.1016/0014-2964(78)90260-8 Geran, 1972, Protocol for screening chemical agents and natural products against animal and other biological systems, Cancer Chemother. Rep., 3, 51 Mussett, 1975, Note on a test of significance for the difference between two proportions, J. biol. Stand., 3, 145, 10.1016/0092-1157(75)90040-2 Schabel, 1969, Spontancous AK leukemia (lymphoma) as a model system, Cancer Chemother. Rep., 53, 329 Di Marco, 1972, Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma, Cancer Chemother. Rep., 56, 153 Sandberg, 1971, Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents, Cancer Chemother. Rep., 55, 233 Double, 1975, Chemotherapy of transplantable adenocarcinomas of the colon in mice, Cancer Chemother. Rep., 59, 1083 Griswold, 1975, A colon tumor model for anticancer agent evaluation, Cancer (Philad.), 36, 2441, 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P Deschner, 1974, Experimentally induced cancer of the colon, Cancer (Philad.), 34, 824, 10.1002/1097-0142(197409)34:3+<824::AID-CNCR2820340707>3.0.CO;2-2 Giuliani, 1973, Combined immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice, Biomedicine, 18, 387 Chirigos, 1961, Response of a virus-induced murine lymphoid leukemia to drug therapy, Cancer Res., 21, 803 Haidle, 1971, Fragmentation of deoxyribonucleic acid by bleomycin, Mol. Pharmacol., 7, 765 Ikawa, 1973, Chemotherapeutic response of epithelial tumors produced by primary implantation of a non-producer line of murine sarcoma virus-transformed BALB/3T3 cells, Cancer Chemother. Rep., 57, 149 Carter, 1972, The chemotherapeutic approach to cancer therapy—a quick overview, Vol. 2, 31 Barranco, 1975, Review of the survival and cell kinetics effects of adriamycin (NSC-123127) on mammalian cells, Cancer Chemother. Rep., 6, 147 Hoover, 1975, Techniques for inhibiting tumor metastases, Cancer (Philad.), 35, 5, 10.1002/1097-0142(197501)35:1<5::AID-CNCR2820350103>3.0.CO;2-1 Gottlieb, 1975, Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas, Cancer Chemother. Rep., 6, 271 Ovejera, 1975, Growth characteristics and chemotherapeutic response of intravenously implanted Lewis lung carcinoma, Cancer Chemother. Rep., 5, 111 Yesair, 1978, Importance of schedule in adriamycin/cyclophosphamide combination chemotherapy, Europ. J. Cancer, 14, 141, 10.1016/0014-2964(78)90172-X Corbett, 1975, Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors, Cancer Res., 35, 1568 Lloyd, 1976, Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a Phase II trial, Cancer Treat. Rep., 60, 77 Jones, 1975, Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer, Cancer (Philad.), 36, 90, 10.1002/1097-0142(197507)36:1<90::AID-CNCR2820360104>3.0.CO;2-H Le Serve, 1972, Metastases and the normalization of tumour blood vessels by ICRF-159: a new type of drug action, Brit. med. J., 1, 597, 10.1136/bmj.1.5800.597 Goldin, 1974, Combination chemotherapy: basic consideration, Vol. I, 410 Corbett, 1978, Isolation of C3H mouse mammary adenocarcinoma suitable for surgery-chemotherapy trials, 19, 114